We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$400B
AUM Growth
+$26.1B
Cap. Flow
-$7.15B
Cap. Flow %
-1.79%
Top 10 Hldgs %
12.04%
Holding
2,531
New
100
Increased
822
Reduced
1,027
Closed
76

Sector Composition

Rank Sector Weight
1 Healthcare 14.66%
2 Consumer Discretionary 13.63%
3 Financials 13.54%
4 Industrials 11.61%
5 Technology 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZ
2426
DELISTED
Enzo Biochem, Inc.
ENZ
$33K ﹤0.01%
13,100
BIOL
2427
DELISTED
Biolase, Inc.
BIOL
$33K ﹤0.01%
1
BAXS
2428
DELISTED
BAXANO SURGICAL INC COM STK (DE)
BAXS
$33K ﹤0.01%
24,000
STSI
2429
DELISTED
STAR SCIENTIFIC INC
STSI
$31K ﹤0.01%
16,200
-3,500
-18% -$6.63K
DBLE
2430
DELISTED
DOUBLE EAGLE PETROLEUM CO
DBLE
$31K ﹤0.01%
10,300
YTEN
2431
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
BXC icon
2432
BlueLinx
BXC
$699M
$24K ﹤0.01%
1,214
+100
+9% +$1.9K
GVP
2433
DELISTED
GSE Systems, Inc.
GVP
$24K ﹤0.01%
1,530
CDXS icon
2434
Codexis
CDXS
$172M
$21K ﹤0.01%
11,859
ALT icon
2435
Altimmune
ALT
$570M
-1,267
Closed -$604K
AMWD
2436
DELISTED
American Woodmark
AMWD
-69,780
Closed -$2.42M
AUB icon
2437
Atlantic Union Bankshares
AUB
$6.06B
-11,029
Closed -$227K
BUD icon
2438
AB InBev
BUD
$156B
-2,700
Closed -$244K
COLM icon
2439
Columbia Sportswear
COLM
$2.88B
-9,562
Closed -$300K
EGY icon
2440
Vaalco Energy
EGY
$601M
-12,700
Closed -$73K
B
2441
Barrick Mining
B
$67.9B
-409,986
Closed -$6.45M
GRFS
2442
Grifois
GRFS
$5.4B
-664,342
Closed -$9.46M
NVMI
2443
Nova
NVMI
$12.9B
-474,800
Closed -$4.3M
PRTS icon
2444
CarParts.com
PRTS
$51.8M
-1,210
Closed -$14K
SF
2445
Stifel
SF
$12.8B
-3,072,422
Closed -$48.7M
SMSI icon
2446
Smith Micro Software
SMSI
$16.9M
-296
Closed -$50K
SOHU
2447
Sohu.com
SOHU
$369M
-24,200
Closed -$1.49M
SSKN
2448
DELISTED
Strata Skin Sciences
SSKN
-207
Closed -$96K
TEVA icon
2449
Teva Pharmaceuticals
TEVA
$42.8B
-404,700
Closed -$15.9M
VRA icon
2450
Vera Bradley
VRA
$97M
-116,800
Closed -$2.53M

Similar funds

T. Rowe Price Associates's Q3 2013 Portfolio in Review

As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
  • T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
  • T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
  • T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
  • T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
  • T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.

Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.